The hypocholesterolemic activity of orally administered polyene macrolides.
AUTOR(ES)
Schaffner, C P
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=285901Documentos Relacionados
- The new macrolides. Azithromycin and clarithromycin.
- Evolution of susceptibilities of Campylobacter spp. to quinolones and macrolides.
- Dissociation between the induction of potassium efflux and cytostatic activity of polyene macrolides in mammalian cells.
- Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides.
- In vitro antimicrobial activity of tigemonam, a new orally administered monobactam.